Literature DB >> 25762417

Whole-Exome Enrichment with the Agilent SureSelect Human All Exon Platform.

Rui Chen1, Hogune Im1, Michael Snyder1.   

Abstract

There are multiple platforms available for whole-exome enrichment and sequencing (WES). This protocol is based on the Agilent SureSelect Human All Exon platform, which targets ∼50 Mb of the human exonic regions. The SureSelect system uses ∼120-base RNA probes to capture known coding DNA sequences (CDS) from the NCBI Consensus CDS Database as well as other major RNA coding sequence databases, such as Sanger miRBase. The protocol can be performed at the benchside without the need for automation, and the resulting library can be used for targeted next-generation sequencing on an Illumina HiSeq 2000 sequencer.
© 2015 Cold Spring Harbor Laboratory Press.

Entities:  

Mesh:

Year:  2015        PMID: 25762417      PMCID: PMC4490097          DOI: 10.1101/pdb.prot083659

Source DB:  PubMed          Journal:  Cold Spring Harb Protoc        ISSN: 1559-6095


  3 in total

1.  Whole-Exome Enrichment with the Illumina TruSeq Exome Enrichment Platform.

Authors:  Rui Chen; Hogune Im; Michael Snyder
Journal:  Cold Spring Harb Protoc       Date:  2015-03-11

2.  Whole-Exome Enrichment with the Roche NimbleGen SeqCap EZ Exome Library SR Platform.

Authors:  Rui Chen; Hogune Im; Michael Snyder
Journal:  Cold Spring Harb Protoc       Date:  2015-03-11

3.  Performance comparison of exome DNA sequencing technologies.

Authors:  Michael J Clark; Rui Chen; Hugo Y K Lam; Konrad J Karczewski; Rong Chen; Ghia Euskirchen; Atul J Butte; Michael Snyder
Journal:  Nat Biotechnol       Date:  2011-09-25       Impact factor: 68.164

  3 in total
  22 in total

1.  Comprehensive Screening for Disease Risk Variants in Early-Onset Alzheimer's Disease Genes in African Americans Identifies Novel PSEN Variants.

Authors:  Aurelie N'Songo; Minerva M Carrasquillo; Xue Wang; Thuy Nguyen; Yan Asmann; Steven G Younkin; Mariet Allen; Ranjan Duara; Maria T Greig Custo; Neill Graff-Radford; Nilüfer Ertekin-Taner
Journal:  J Alzheimers Dis       Date:  2017       Impact factor: 4.472

Review 2.  Whole exome sequencing: a state-of-the-art approach for defining (and exploring!) genetic landscapes in pediatric nephrology.

Authors:  Ashima Gulati; Stefan Somlo
Journal:  Pediatr Nephrol       Date:  2017-06-29       Impact factor: 3.714

Review 3.  The potential of cerebrospinal fluid-based liquid biopsy approaches in CNS tumors.

Authors:  Austin K Mattox; Hai Yan; Chetan Bettegowda
Journal:  Neuro Oncol       Date:  2019-12-17       Impact factor: 12.300

4.  Targeted capture enrichment and sequencing identifies extensive nucleotide variation in the turkey MHC-B.

Authors:  Kent M Reed; Kristelle M Mendoza; Robert E Settlage
Journal:  Immunogenetics       Date:  2016-01-05       Impact factor: 2.846

5.  Whole-Exome Enrichment with the Illumina TruSeq Exome Enrichment Platform.

Authors:  Rui Chen; Hogune Im; Michael Snyder
Journal:  Cold Spring Harb Protoc       Date:  2015-03-11

6.  Whole-Exome Enrichment with the Roche NimbleGen SeqCap EZ Exome Library SR Platform.

Authors:  Rui Chen; Hogune Im; Michael Snyder
Journal:  Cold Spring Harb Protoc       Date:  2015-03-11

7.  Consensus coding sequence (CCDS) database: a standardized set of human and mouse protein-coding regions supported by expert curation.

Authors:  Shashikant Pujar; Nuala A O'Leary; Catherine M Farrell; Jane E Loveland; Jonathan M Mudge; Craig Wallin; Carlos G Girón; Mark Diekhans; If Barnes; Ruth Bennett; Andrew E Berry; Eric Cox; Claire Davidson; Tamara Goldfarb; Jose M Gonzalez; Toby Hunt; John Jackson; Vinita Joardar; Mike P Kay; Vamsi K Kodali; Fergal J Martin; Monica McAndrews; Kelly M McGarvey; Michael Murphy; Bhanu Rajput; Sanjida H Rangwala; Lillian D Riddick; Ruth L Seal; Marie-Marthe Suner; David Webb; Sophia Zhu; Bronwen L Aken; Elspeth A Bruford; Carol J Bult; Adam Frankish; Terence Murphy; Kim D Pruitt
Journal:  Nucleic Acids Res       Date:  2018-01-04       Impact factor: 16.971

Review 8.  Genome annotation for clinical genomic diagnostics: strengths and weaknesses.

Authors:  Charles A Steward; Alasdair P J Parker; Berge A Minassian; Sanjay M Sisodiya; Adam Frankish; Jennifer Harrow
Journal:  Genome Med       Date:  2017-05-30       Impact factor: 11.117

9.  Causal variants screened by whole exome sequencing in a patient with maternal uniparental isodisomy of chromosome 10 and a complicated phenotype.

Authors:  Niu Li; Y U Ding; Tingting Yu; Juan Li; Yongnian Shen; Xiumin Wang; Qihua Fu; Yiping Shen; Xiaodong Huang; Jian Wang
Journal:  Exp Ther Med       Date:  2016-04-11       Impact factor: 2.447

10.  Mutations of METTL3 predict response to neoadjuvant chemotherapy in muscle-invasive bladder cancer.

Authors:  Zhao Yang; Zongyi Shen; Di Jin; Nan Zhang; Yue Wang; Wanjun Lei; Zhiming Zhang; Haige Chen; Faiza Naz; Lida Xu; Lei Wang; Shihui Wang; Xin Su; Changyuan Yu; Chong Li
Journal:  J Clin Transl Res       Date:  2021-06-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.